Salvage therapy of reactive capillary hemangiomas: Apatinib alleviates the unique adverse events induced by camrelizumab in non-small cell lung cancer | J Cancer Res Ther; 2020 Jan; 15(6): 1624-1628 | IMSEAR

Main content 1 Search 2 Footer 3

+A A -A High contrast

Salvage therapy of reactive capillary hemangiomas: Apatinib alleviates the unique adverse events induced by camrelizumab in non-small cell lung cancer

Li, Wenhong; Wei, Zhigang; Yang, Xia; Huang, Guanghui; Han, Xiaoying; Ni, Yang; Wang, Jiao; Meng, Min; Zou, Zhigeng; Wen, Qiang; Ye, Xin.

J Cancer Res Ther ; 2020 Jan; 15(6): 1624-1628

Article | IMSEAR | ID: sea-213581

Key words

Apatinib; camrelizumab; non-small cell lung cancer; reactive capillary hemangiomas

Search on Google

Full text: 1 Index: IMSEAR Type of study: Observational_studies Journal: J Cancer Res Ther Journal subject: Neoplasms / Therapeutics Year: 2020 Type: Article

Search on Google

Full text: 1 Index: IMSEAR Type of study: Observational_studies Journal: J Cancer Res Ther Journal subject: Neoplasms / Therapeutics Year: 2020 Type: Article